Mr. David Mitchell reports

AMERICAN ATOMICS ANNOUNCES THE CREATION OF A FORMAL ADVISORY BOARD WITH FORMER WHITE HOUSE COUNCIL OF ECONOMIC ADVISERS CHAIRMAN DR. TOMAS J. PHILIPSON AS CHAIRMAN

Dr. Tomas J. Philipson has agreed to serve as chair of American Atomics Inc.'s advisory board.

Dr. Philipson is a leading economist and public policy scholar who served at the White House as a member, vice-chairman and acting chairman of the President's Council of Economic Advisers. He has also held senior advisory roles within the U.S. federal government, including as senior economic adviser to the heads of the U.S. Food and Drug Administration and Centers for Medicare & Medicaid Services.

During his White House service, the chairman of the Council of Economic Advisers was a named member of the U.S. Nuclear Fuel Working Group, which was established to develop recommendations for reviving and expanding domestic nuclear fuel production. This experience aligns closely with American Atomics' strategy of supporting U.S. objectives around uranium supply, nuclear fuel independence and allied energy security.

As advisory board chair, Dr. Philipson is expected to advise American Atomics on U.S. policy alignment, strategic positioning, federal engagement, economic framing and the company's broader effort to support domestic nuclear fuel cycle independence. Dr. Philipson has been granted 500,000 options with a term of three years, an exercise price of 35 cents and vesting in four equal tranches on a quarterly basis.

American Atomics is pursuing a rocks-to-reactor strategy focused on advancing United States-aligned uranium and nuclear fuel cycle opportunities, including uranium exploration, milling and related technologies. The company's strategy is designed to align with U.S. national objectives around energy security, critical minerals, nuclear fuel availability and reduced reliance on foreign-controlled nuclear fuel supply chains.

American Atomics is also a member of the U.S. Department of Energy's Defense Production Act Nuclear Fuel Cycle Consortium, which was established to support coordination across the domestic nuclear industrial base, including mining and milling, conversion, enrichment, deconversion, fabrication, recycling, and reprocessing.

"Dr. Philipson brings extraordinary public policy, economic and federal government experience to American Atomics at a pivotal time for the U.S. nuclear fuel cycle," said David Mitchell, chief executive officer of American Atomics. "The United States has made clear that nuclear energy, domestic uranium supply and fuel cycle independence are matters of national and economic security. Dr. Philipson's experience at the highest levels of U.S. economic policymaking will be invaluable as we work to position American Atomics as a serious participant in the rebuilding of a secure North American nuclear fuel cycle."

"I am pleased to chair the advisory board of American Atomics as the company works to support the strategic rebuilding of domestic nuclear fuel cycle capabilities," said Dr. Philipson. "Reliable nuclear energy and secure fuel supply chains are increasingly important to U.S. energy security, industrial competitiveness and long-term economic growth. I look forward to advising the company as it advances its strategy."

The company believes Dr. Philipson's appointment strengthens American Atomics' ability to communicate its strategy to investors, policymakers and industry partners, particularly as the United States accelerates efforts to expand nuclear power generation and rebuild domestic nuclear fuel cycle capacity.

Formal advisory board

With the addition of Dr. Philipson to the advisory board and as chairman, the company has decided to create a formal advisory board, including its current advisers and Dr. Philipson.

The advisory board will consist of Dr. Philipson (chairman), Dr. Erik Hunter, Adam Falkoff, Paul Szilagyi and Craig Howell.

"We believe that key, experienced and value-add advisers can be a significant piece in a company's eventual success and its ability to execute on its plans. This initial board is a great start to that and we look forward to building it further over time with additional members," stated Mr. Mitchell.

Option grants

The company also announces that it has granted stock options to certain directors, officers and consultants of the company to purchase an aggregate 3.51 million common shares in the capital of the company pursuant to the company's share option plan. The options are exercisable at an exercise price of 35 cents per share. Two million sixty thousand of the options have a term of three years and 1.45 million of the options have a term of five years. One million eight hundred sixty thousand of the options are subject to vesting periods over the course of the term of the options, whereas the remaining 1.65 million options vest immediately.

Dr. Philipson is the Daniel Levin professor of public policy studies emeritus at the University of Chicago Harris School of Public Policy. He has served in senior U.S. federal policy roles, including as member, vice-chairman and acting chairman of the President's Council of Economic Advisers, and as senior economic adviser to the heads of the FDA and CMS. His work has focused on public policy, economic analysis, regulation, health care markets, innovation and the economic impact of federal policy.

About American Atomics Inc.

American Atomics is a uranium and nuclear fuel cycle company focused on advancing a North American rocks-to-reactor strategy. The company is pursuing opportunities across uranium exploration and development, milling and related technologies, with a focus on supporting secure, domestic and allied nuclear fuel supply chains.

We seek Safe Harbor.